MXD3 and adrenal cortex carcinoma: Patients suffering from ACC (Figure 8H, p = 0.005), KIRC (Figure 8I, p = 0.002), KICH (Figure 8J, p = 0.051), and SKCM (Figure 8K, p = 0.053) with stage IV versus stage I had higher MXD3 expression.